Fully automated viability and toxicity screening—A reliable all‐in‐one attempt
Abstract Background The CRISPR/Cas9 technology is nowadays a common tool for genome editing to achieve new insights into, for example, diagnostics and therapeutics in cancer and genetic disorders. Cell proliferation and anticancer drug response studies are widely used to evaluate the impact of editi...
| 發表在: | Cancer Medicine |
|---|---|
| Main Authors: | , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Wiley
2024-06-01
|
| 主題: | |
| 在線閱讀: | https://doi.org/10.1002/cam4.7392 |